Skip to content

Spinal anesthesia additives

Ketamine versus Tramadol as an adjuvant to Bupivacaine in Spinal anesthesia

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230813059138N1
Enrollment
120
Registered
2023-08-23
Start date
2023-08-26
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

additives in spinal anesthesia. Ovarian cyst, unilateral. unspecified

Interventions

Intervention 1: Control group: receiving 2ml of hyperbaric bupivacaine 0.5%. After Fasting period of 6 hours, patient received intravenous preload of 10 ml/kg of either N/S or ringer solution. No prem

Sponsors

University of Sousse, Faculty of Medicine Ibn Al Jazzar
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 45 Years

Inclusion criteria

Inclusion criteria: Female Age between (16-45 years) ASA class 1 or 2 elective open unilateral ovarian cystectomy

Exclusion criteria

Exclusion criteria: spine deformity bleeding tendency neurological diseases history of scorpion bite patient disapproval

Design outcomes

Primary

MeasureTime frame
Primary outcome were the onset and duration of both sensory and motor block, and the duration of spinal analgesia. Timepoint: 3 days after intervention. Method of measurement: sensory block by pinprick, while the motor block observed by modified bromage score.

Secondary

MeasureTime frame
The secondary outcome were, nausea, vomiting, sedation, shivering, heart rate, mean arterial pressure. Timepoint: directly after intervention till 3 days after intervention. Method of measurement: inspection (visually) observation.

Countries

Iraq

Contacts

Public ContactDr. Mohamad Kahloul

University of Sousse, Ibn Al Jazzar College of medicine

famso@famso.rnu.tn+216 73 222 600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026